v3.22.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Operating activities:    
Consolidated net income $ 222.8 $ 202.9
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 139.3 116.7
Stock-based compensation expense 22.3 20.7
Deferred income taxes 40.2 23.1
(Gain) loss on fair market value adjustment of equity investments (8.3) 11.9
(Gain) on divestiture 0.0 (0.2)
Changes in assets and liabilities, excluding effects of acquisitions:    
Accounts receivable, net (124.9) (65.8)
Other assets, current and long-term (0.6) 14.7
Current and long term liabilities, excluding debt (489.3) (180.6)
Cash (used in) provided by operating activities (198.5) 143.4
Investing activities:    
Capital expenditures (156.5) (113.0)
Acquisitions, net of cash acquired (111.7) (862.0)
Cash received from divestiture 0.0 1.5
Cash used in investing activities (268.2) (973.5)
Financing activities:    
Net short-term borrowings 516.8 (0.7)
Treasury stock purchases 0.0 (34.1)
Dividends paid to Equifax shareholders (47.9) (47.5)
Dividends paid to noncontrolling interests (0.5) (0.7)
Proceeds from exercise of stock options and employee stock purchase plan 5.7 6.6
Payment of taxes related to settlement of equity awards (29.8) (8.6)
Purchase of noncontrolling interests 0.0 (3.6)
Cash provided by (used in) financing activities 444.3 (88.6)
Effect of foreign currency exchange rates on cash and cash equivalents (1.4) 0.0
Decrease in cash and cash equivalents (23.8) (918.7)
Cash and cash equivalents, beginning of period 224.7 1,684.6
Cash and cash equivalents, end of period $ 200.9 $ 765.9

Source